What changes for medical device manufacturers and distributors?
The effort required to re-authorise an implant or other medical device for sale in the European Union increases significantly under the new rules:
- Because a new classification scheme has been introduced, manufacturers will have to reclassify their entire product portfolio
- In future, clinical studies will be required for many products that could previously claim similarity to existing medical devices
- Duties of care and documentation are more demanding and also apply to the supply chain
Distributors who import medical goods outside the EU as distributors will in future be obliged to check the certificates of the products and ensure their conformity.
Both producers and manufacturers of medical technology should intensify their supplier management and establish a structured risk management. The intelligent use of digital solutions in procurement and supply chain management helps to save time and costs.
Cost pressure is increasing
For manufacturers and retailers, the new rules mean more time and higher costs. New approaches to cost management are necessary so that these do not lead to declining profitability. We develop an individual programme for you, which we can also implement together with your employees if you wish. With customised procurement training, we support you in sustainably anchoring the newly acquired knowledge in the company.
Do you have any questions or would you like to find out more about our MedTech services? We look forward to hearing from you![contact-form-7 id=”2901″ title=”Kontaktformular EN”]